ArticleFrontiers in oncology2026

Ten-year risk of second primary malignancies among chemotherapy-treated early-stage breast cancer survivors: a multicentre cohort study from the Turkish Oncology Group.

Haydar Cagatay Yuksel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.